Tenogenic potential of tendon-derived mesenchymal stem cells isolated post-mortem: Impact of cryopreservation.
Abstract: In situ injection of mesenchymal stem cells appears as a promising treatment of tendinopathies. Tendon-derived mesenchymal stem cells (TDSCs) are widely studied and show a lot of interesting characteristics for clinical use. The aim of this study is to confirm the tenogenic potential of cryopreserved TDSCs and to confirm their ability to produce type I and/or type III collagens fibers in culture. Tendon-derived mesenchymal stem cells are harvested from the tendon no later than 72 h post-mortem. Their tenogenic potential has been assessed by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis of different genes involved in tenogenic differentiation. The stemness phenotype of TDSCs has been confirmed by flow cytometry. In order to demonstrate their capacity to synthesize type I and III collagen fibers, a stimulation with Transforming Growth Factor-β1(TGF-β1) has been performed in culture. TDSCs comply with the expected phenotype of mesenchymal stem cells as defined by ISCT. All the samples and conditions analyzed by flow cytometry were positive for CD105, CD90, CD29, CD44 and negative for MHC-II. Their tenogenic potential is also confirmed by qRT-PCR. TDSCs are metabolically active cells, showing an ultrastructure reflecting high level of proteins synthesis. Moreover, they are able to synthetize collagen fibers under stimulation by TGF-β1. Freshly harvested or cryopreserved TDSCs are involved in the tenogenic pathway and are able to produce an extracellular collagenous network. These properties make them suitable for banking and subsequent clinical use for contributing to tendon repair.
Copyright © 2025 Elsevier Ltd. All rights reserved.
Publication Date: 2025-05-29 PubMed ID: 40472780DOI: 10.1016/j.rvsc.2025.105722Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research study explores the potential use of tendon-derived mesenchymal stem cells (TDSCs) in treating tendinopathies (tendon injuries), and asserts that even after cryopreservation (freezing), these cells retain their ability to produce crucial types of collagen necessary for tendon repair.
Objective of the Study
- The main aim of this research was to investigate the ‘tenogenic’ potential (i.e., the capacity to form tendon tissue) of TDSCs post-cryopreservation, by evaluating their ability to produce type I and III collagen fibers. These particular types of collagen are integral to the construction and repair of tendon tissue.
Methodology of the Study
- TDSCs were harvested from the tendon within 72 hours post-mortem and their ‘stemness’ phenotype, essentially their stem-cell qualities, were analyzed with flow cytometry, a technology used to measure the physical and chemical characteristics of cells.
- The tenogenic potential of these cells was assessed through a technique called quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). This method helped to analyze gene expression connected to tenogenic differentiation, or the process by which the TDSCs could develop into tendon tissue.
- To understand the ability of TDSCs to synthesize type I and III collagen fibers, they were cultured with Transforming Growth Factor-β1(TGF-β1), which is known to stimulate such processes.
Results and Findings of the Study
- All samples/conditions analyzed were positive for specific markers (CD105, CD90, CD29, CD44) and negative for MHC-II, aligning with the expected phenotype of mesenchymal stem cells as per the International Society for Cellular Therapy (ISCT).
- The analyses confirmed the tenogenic potential of TDSCs through qRT-PCR, indicating that these cells can indeed evolve into tendon tissue.
- Furthermore, under the influence of TGF-β1, TDSCs demonstrated the crucial ability to synthesize collagen fibers.
- The study affirmed that TDSCs, whether freshly harvested or cryopreserved, actively contribute to the tenogenic pathway. This means they could be effectively mobilized towards tendon repair when required.
Implications and Conclusion
- The study concludes that TDSCs possess qualities making them suitable for banking and subsequent clinical use for tendon repair. As cryopreservation does not affect their fundamental capabilities, these cells can be stored, increasing the feasibility and accessibility of this potentially effective treatment.
Cite This Article
APA
Marine L, Wilfried P, Joëlle P, Justine J, Axel D, Vinciane T, Benoît V, Laurent G, Luc G, Jean-François K, Nadine A.
(2025).
Tenogenic potential of tendon-derived mesenchymal stem cells isolated post-mortem: Impact of cryopreservation.
Res Vet Sci, 193, 105722.
https://doi.org/10.1016/j.rvsc.2025.105722 Publication
Researcher Affiliations
- Department of Morphology and Pathology, Histology, FARAH, Quartier Vallée 2, B43a, Uliège, 4000 Liège, Belgium. Electronic address: marine.levoz@uliege.be.
- Department of Infectious and Parasitic Diseases, Mycology-Parasitology, FARAH, Quartier Vallée 2, B43a, Uliège, 4000 Liège, Belgium. Electronic address: Wilfried.Poirier@uliege.be.
- Department of Morphology and Pathology, Histology, FARAH, Quartier Vallée 2, B43a, Uliège, 4000 Liège, Belgium. Electronic address: jpiret@uliege.be.
- Department of Infectious and Parasitic Diseases, Immunology-Vaccinology, FARAH, Quartier Vallée 2, B43b, Uliège, 4000 Liège, Belgium. Electronic address: Justine.Javaux@uliege.be.
- Department of Morphology and Pathology, Embryology, FARAH, Quartier Vallée 2, B43a, Uliège, 4000 Liège, Belgium. Electronic address: axel.dubois@uliege.be.
- Department of Morphology and Pathology, Histology, FARAH, Quartier Vallée 2, B43a, Uliège, 4000 Liège, Belgium. Electronic address: vtoppets@uliege.be.
- Department of Morphology and Pathology, Embryology, FARAH, Quartier Vallée 2, B43a, Uliège, 4000 Liège, Belgium. Electronic address: B.Vandenhove@uliege.be.
- Department of Infectious and Parasitic Diseases, Mycology-Parasitology, FARAH, Quartier Vallée 2, B43a, Uliège, 4000 Liège, Belgium. Electronic address: L.Gillet@uliege.be.
- Department of Morphology and Pathology, Embryology, FARAH, Quartier Vallée 2, B43a, Uliège, 4000 Liège, Belgium. Electronic address: lgrobet@uliege.be.
- Physical Medicine Service and Department of Motility Sciences, GIGA, Avenue de l'Hôpital 11, B34, Uliège, 4000 Liège, Belgium. Electronic address: jfkaux@uliege.be.
- Department of Morphology and Pathology, Histology, FARAH, Quartier Vallée 2, B43a, Uliège, 4000 Liège, Belgium. Electronic address: Nadine.antoine@uliege.be.
Conflict of Interest Statement
Declaration of competing interest Authors declare no conflicts of interest.
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists